Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Clinical trial NCT01061177 · COMPLETED
Trial details
- NCT number
- NCT01061177
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 1090
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.